Leadership Overview
Enovis has 8 executives leading key functions including strategy, finance, operations, and product development.
Driven by a culture of continuous improvement, Enovis is dedicated to improving lives by creating clinically differentiated solutions that help restore motion and enhance patient outcomes, partnering with experts to advance smarter, personalized, and more effective care.
Driven by a culture of continuous improvement, Enovis is dedicated to improving lives by creating clinically differentiated solutions that help restore motion and enhance patient outcomes, partnering with experts to advance smarter, personalized, and more effective care.
Leadership Roles at Enovis
Damien McDonald - Chief Executive Officer
Damien McDonald, the Chief Executive Officer at Enovis, directs the overarching corporate strategy and vision. McDonald guides the company's mission to improve lives by creating clinically differentiated solutions that restore motion and enhance patient outcomes. This leadership involves fostering partnerships with healthcare experts to advance smarter, personalized, and more effective care. Overseeing global operations, the Chief Executive Officer ensures alignment with the company's culture of continuous improvement, innovation, and strategic growth. By driving the development of a broad portfolio of products, services, and integrated technologies, Damien McDonald directly impacts the company's market position and commitment to supporting patients throughout their journey to better health. Ultimately, McDonald secures Enovis's long-term financial stability and market leadership.

Benjamin Berry - Chief Financial Officer
Benjamin Berry, the Chief Financial Officer at Enovis, manages all financial operations and strategic financial planning. Berry oversees the fiscal health of the organization, ensuring robust financial controls and driving profitable growth. This role involves close collaboration with other executive leaders to allocate capital effectively and support the company's mission of enhancing patient outcomes through medical technology innovation. By directing financial reporting and analysis, the Chief Financial Officer provides critical insights that inform strategic decision-making across all business units. Benjamin Berry is instrumental in managing investor relations and maintaining the company's strong financial standing. Ultimately, Berry ensures the company's financial strategies directly support Enovis's commitment to advancing smarter, personalized, and more effective care globally.
Judith MacGowan - Regional Chief Financial Officer (APAC)
Judith MacGowan, the Regional Chief Financial Officer (APAC) at Enovis, directs financial strategy and operations across the Asia-Pacific region. MacGowan ensures financial compliance and drives fiscal performance within this key geographic market, supporting Enovis's global expansion and commitment to improving patient outcomes. This leadership position involves managing regional budgets, forecasting, and financial reporting to align with the company's overarching mission of advancing smarter, personalized medical technologies. By overseeing financial planning and analysis for APAC, Judith MacGowan provides essential support to regional leadership and contributes to the company's strategic growth objectives. Ultimately, MacGowan strengthens Enovis's presence in the APAC market through sound financial stewardship and operational efficiency.
Chi Egwuekwe - Vice President, Finance & Chief Financial Officer, Prevention & Recovery
Chi Egwuekwe, the Vice President, Finance & Chief Financial Officer, Prevention & Recovery at Enovis, leads financial operations for the Prevention & Recovery segment. Egwuekwe manages the financial health and strategic planning for this critical business unit, ensuring its contribution to Enovis's mission of restoring motion and enhancing patient outcomes. This role involves detailed financial analysis, budgeting, and forecasting to support product development and market penetration within the prevention and recovery space. By overseeing financial performance, the Vice President, Finance & Chief Financial Officer, Prevention & Recovery ensures operational efficiency and profitability for the segment. Chi Egwuekwe's financial acumen directly supports the advancement of clinically differentiated solutions that improve patient journeys and strengthen Enovis's market leadership.
Barbara Serkin - Executive Assistant To Chief Human Resources Officer, P & R Group President and Senior Vice President, Supply Chain and Operations
Barbara Serkin, the Executive Assistant To Chief Human Resources Officer, P & R Group President and Senior Vice President, Supply Chain and Operations at Enovis, provides critical administrative and operational support. Serkin facilitates seamless communication and workflow between key executive functions, including human resources, the Prevention & Recovery Group President, and the Senior Vice President of Supply Chain and Operations. This role is essential for maintaining organizational efficiency and supporting the strategic initiatives that drive Enovis's mission to improve lives through medical technology. By managing schedules, coordinating meetings, and handling essential documentation, Barbara Serkin ensures that these vital leaders can focus on advancing smarter, personalized care and enhancing patient outcomes. Serkin's support directly contributes to the smooth operation of critical business segments.
Terry Ross - Group President, Prevention and Recovery
Terry Ross, the Group President, Prevention and Recovery at Enovis, leads the strategic direction and operational execution for the Prevention and Recovery business segment. Ross drives the development and commercialization of innovative solutions designed to restore motion and enhance patient outcomes in this critical area of healthcare. This leadership role involves overseeing product portfolios, market strategies, and cross-functional teams to ensure alignment with Enovis's mission of advancing smarter, personalized care. By focusing on the specific needs of patients and clinicians in prevention and recovery, Terry Ross ensures the delivery of clinically differentiated technologies. Ross's leadership directly contributes to the segment's growth and its impact on improving quality of life for individuals seeking better health.
Gary Justak - Global President and General Manager, Foot & Ankle
Gary Justak, the Global President and General Manager, Foot & Ankle at Enovis, directs the strategic vision and operational performance for the Foot & Ankle division. Justak spearheads initiatives to advance clinically differentiated solutions that improve patient outcomes in this specialized medical field. This leadership position involves managing global product lines, market expansion, and fostering key relationships with healthcare professionals to support the company's mission. By overseeing the entire lifecycle of Foot & Ankle products, Gary Justak ensures innovation and market leadership. Justak's focus on enhancing patient mobility and recovery directly supports Enovis's broader commitment to restoring motion and advancing personalized care. Ultimately, Justak drives the growth and success of the Foot & Ankle segment worldwide.
Louie Vogt - Group President, Reconstructive
Louie Vogt, the Group President, Reconstructive at Enovis, leads the strategic development and operational management of the Reconstructive business segment. Vogt drives the innovation and delivery of advanced medical technologies aimed at restoring function and improving patient quality of life. This executive role involves overseeing product portfolios, market strategies, and collaborative efforts with healthcare providers to ensure the highest standards of care. By focusing on the reconstructive needs of patients, Louie Vogt ensures that Enovis provides cutting-edge solutions that enhance surgical outcomes and patient recovery. Vogt's leadership directly contributes to the segment's growth and reinforces Enovis's commitment to advancing smarter, personalized medical treatments and enhancing patient journeys.
Oliver Engert - Chief Administrative Officer
Oliver Engert, the Chief Administrative Officer at Enovis, oversees essential corporate functions that support the company's operational infrastructure and strategic objectives. Engert ensures the efficient management of administrative processes, enabling Enovis to effectively deliver on its mission of improving lives by creating clinically differentiated solutions. This leadership role involves optimizing internal operations and fostering a culture that supports innovation and strategic growth across the organization. By directing key administrative departments, the Chief Administrative Officer ensures that Enovis can effectively partner with healthcare experts and advance smarter, personalized care. Oliver Engert's focus on operational excellence directly contributes to enhancing patient outcomes and supporting the company's broad portfolio of products and services.

Explore Leadership Teams in Manufacturing
Integer® Holdings Corporation (NYSE:ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular and portable medical markets. The company provides innovative, high-quality technologies and manufacturing to Medical Device OEMs to enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. Greatbatch Medical®, Lake Region Medical® and Electrochem® comprise the companys brands. Our story is one filled with 80 years of industry-changing innovations and exemplary manufacturing. Its a legacy we are proud of as we continue to provide customers with unparalleled expertise, innovation and manufacturing excellence. We are guided by our values of Innovation, Collaboration, Inclusion, Candor, Integrity and Customer.
Company Leadership
JC

DS
Accuray develops and manufactures advanced radiation oncology systems designed to deliver precise cancer treatment solutions. The company specializes in creating innovative medical devices that enable clinicians to target tumors with exceptional accuracy while minimizing exposure to surrounding healthy tissue. This focus on precision has shaped the organization's technical approach and product development strategy across its portfolio. The company's radiation oncology systems integrate sophisticated imaging, planning, and delivery technologies to support comprehensive cancer care. By combining real-time imaging capabilities with adaptive treatment planning, Accuray's platforms allow medical teams to adjust therapy in response to anatomical changes during treatment courses. This technological integration addresses a critical challenge in oncology: maintaining treatment efficacy while reducing potential side effects that can impact patient quality of life. Accuray serves hospitals, cancer treatment centers, and specialized radiation oncology facilities globally. The company's systems support treatment of various cancer types across different anatomical sites, from brain and head-and-neck tumors to thoracic and abdominal malignancies. Healthcare providers rely on Accuray's technology to expand their treatment capabilities and improve clinical outcomes for patients who might otherwise have limited options.
Company Leadership KT
MR

Peijia Medical is a global provider of innovative medical products and solutions, focusing on high-end medical devices in the fields of structural heart disease and neurovascular interventions. The company offers a comprehensive range of products including aortic, mitral, and tricuspid valves, as well as surgical accessories and neurovascular intervention products. With a commitment to continuous innovation, Peijia aims to provide safe, effective, and accessible solutions to improve patient quality of life. Their target clients include hospitals and healthcare providers dealing with cardiovascular and neurovascular diseases.
Company Leadership MZ
JT
LT

Founded in 2011 and headquartered in Selangor, Malaysia, IDS Medical Systems is a medical supply chain solutions company in Asia.
Company Leadership BC
AR
CK
RS